EcoDrugPlus

Adrenoceptor Alpha 2c

Ensembl ID : ENSLACG00000005416
Gene Symbol: ADRA2C
4 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSLACG00000010371
Gene Symbol: ADRB1
4 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSLACG00000003531
Gene Symbol: ADRB2
4 Cross references
263 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSLACG00000002602
Gene Symbol: ADRB3
4 Cross references
215 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSLACG00000006386
Gene Symbol: AKR1B1
4 Cross references
438 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSLACG00000017791
Gene Symbol: GAA
3 Cross references
234 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSLACG00000011748
Gene Symbol: AOC1
4 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSLACG00000004727
Gene Symbol: AOC3
4 Cross references
410 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSLACG00000001469
Gene Symbol: APP
4 Cross references
276 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSLACG00000015024
Gene Symbol: AR
2 Cross references
277 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSLACG00000006082
Gene Symbol: AGTR1
4 Cross references
207 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSLACG00000009418
Gene Symbol: AGTR2
4 Cross references
191 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).